RAN and hepatocellular carcinoma: Specifically, the RAN rs3803012 variant was associated with the elevated risk of persistent HBV infection and subsequent HBV‐related HCC [140], suggesting a link between impaired pre‐miRNA transport and hepatocarcinogenesis.